Y Combinator is a startup accelerator that invests in a large number of startups twice a year. It created a new model for funding startups. Twice a year, the company invests a small amount of money ($150k) in a large number of startups. The startup accelerator works intensively with the companies for three months, to get them into the best possible shape and refine their pitch to investors. Each cycle culminates in Demo Day when the startups present their companies to a carefully selected, invite-only audience.

Y Combinator

Coughdrop Capital is an early-stage venture firm based in San Francisco and Los Angeles.Typically, we write checks into pre-seed or seed stage startups. Regardless of sector, industry, or stage, we like to fund smart founders with ambitious plans. We love warm intros, but don't require them.  Say hello!

Coughdrop Capital

BossaNova is the number one Brazilian Micro Venture Capital. We are the most active investor in the pre-seed stage in Latin America with more than 1200 investments in over 1000 Startups. We also invest in global companies, directly or through co-investment syndicates on AngelList.

Bossanova Investimentos

Pioneer Fund is a fund of 420+ Y Combinator alumni, investing in the top Y Combinator startups.

Pioneer Fund

Bee Partners is a pre-seed deep tech venture firm.  We write Founders their first check and partner on their journey from zero to one.  These founders have the smarts, grit, and humanity to create the machines of tomorrow in AI/ML, Robotics, Automation, Synthetic Biology, and more.   Bee Partners is a collective of builders, designers, entrepreneurs, operators, and technologists with experience across big tech, startups, [research labs] and more.  We share a common goal: to deliver outcomes in the form of customers, ROI and venture-scale returns for our Founders, enterprise partners, and investors.  Our approach has led the portfolio to a 60%+ matriculation rate to Series A. Bee’s portfolio companies realize accelerated growth and have secured over $1.8B in follow-on capital from the world's top VCs.

Bee Partners

We invest in high-impact, early-stage founders using technology  to leave the world a better place. We lead and follow.

Narrative Fund

Based in Singapore, GROW is an ecosystem catalyst advancing innovation, sustainability, and resilience in the food system. We’re on a mission to inspire and accelerate extraordinary founders who are developing technology solutions that deliver positive impact for people, place, and planet. Through our fund and accelerator programs we work with startups to supercharge their growth on the global stage. GROW is supported by Enterprise Singapore and backed by leading agrifoodtech VC AgFunder.

GROW Agrifoodtech Accelerator

Toyota Ventures is a San Francisco Bay Area-based venture capital firm that invests in early-stage startups from around the world. Founded in July 2017, its mission is to discover what’s next for Toyota by helping startups bring disruptive technologies and business models to market quickly. With more than $500 million in assets under management, the firm’s funds include the Toyota Ventures Frontier Fund focused on artificial intelligence, cloud computing, autonomy, mobility, robotics, smart cities, digital health, financial technologies, materials, and energy; and the Toyota Ventures Climate Fund focused on innovative solutions for carbon neutrality.

Toyota Ventures

AgFunder invests in impactful companies that can positively transform the world's food system. Founded in 2013, AgFunder manages a portfolio of over 50 companies across four funds from offices in Silicon Valley and Singapore. Through its media platform AFN, it has built a global ecosystem of over 90,000 subscribers.

AgFunder

Builders VC is an early-stage venture capital firm focused on investing where technology meets new business models to modernize antiquated industries including healthcare, agriculture, industrials and real-estate.

Builders VC

Amplify Capital is the evolution of the MaRS Catalyst Fund, investing in mission-driven, double-bottom-line disruptors in health, education and clean tech. Every dollar invested in these companies generates a financial return and a social return. That’s how they amplify capital. And they further amplify their impact by encouraging partners, investors and co-investors to invest in companies where purpose drives profit. As investors, what they invest in today shapes the world of tomorrow.

Amplify Capital

Climate Capital is an investment firm that supports companies that directly or indirectly reduce global greenhouse gas emissions.

Climate Capital

Siddhi Capital is the venture partner for convention-crushing food and beverage companies. It blends deep operating knowledge and expertise through its strategic partnership with Siddhi Ops, and smart capital to propel brands forward in the food and beverage marketplace.

Siddhi Capital

GC Foodtech Ventures is a corporate-based venture capital firm that invests in the foodtech sector. Founded in 2019, the firm is consists of a team of experienced investment professionals and former food/beverage operators who invests in bold entrepreneurs leading the technology revolution in the global food industry.

Green Circle Foodtech Ventures

Future Fields

Future Fields is committed to producing sustainable components for science through insect biotechnology. Its EntoEngine™ platform is the first to harness the genetic prowess of fruit flies to produce Earth’s most environmentally and economically sustainable biomolecules. Founded in 2018, Future Fields is headquartered in Edmonton, Canada and proudly backed by marquee venture capital firms and investors from Silicon Valley and beyond. Learn more about how Future Fields is enabling great science at https://futurefields.io/.

Future Fields is a Canadian biotech startup developing recombinant proteins using its patented EntoEngine™ technology. This tech uses the common fruit fly (Drosophila melanogaster) to create key biomolecules for various industries, including cultured meat, medical research, and biopharmaceuticals. The company claims this is faster, more sustainable, and more scalable than traditional bioreactors. The company’s current product lineup includes several serum-free growth factors (FGF2, ENTO-F, ENTO-TF) that can be used in the production of cultivated meat.

Making meat sustainable over the long term

Cell-cultured Meat

Instar 1.0: Future Fields' Biofactory Revolutionizes Protein Production

Future Fields is a Canadian biotech startup developing recombinant proteins using its patented EntoEngine™ technology. This tech uses the common fruit fly (Drosophila melanogaster) to create key biomolecules for various industries, including cultured meat, medical research, and biopharmaceuticals. The company claims this is faster, more sustainable, and more scalable than traditional bioreactors. The company’s current product lineup includes several serum-free growth factors (FGF2, ENTO-F, ENTO-TF) that can be used in the production of cultivated meat.Funding and financialsIn <a href="https://sp-edge.com/updates/16627">February 2023</a>, Future Fields raised USD 11.2 million in funding from venture capitalists and government contracts, including Bee Partners and Toyota Ventures. The funds raised were to be used to open a production facility and grow the team.

Mosa Meat is a Dutch cell-cultured meat startup founded by Dr. Mark Post of Maastricht University, and was the first-ever company to produce a lab-grown meat burger. The startup produces meat by growing myosatellite cells (muscle stem cells) extracted from an animal in a bioreactor fed with a nutrient-dense medium.The company replaced the fetal bovine serum (FBS) from its growth medium in July 2020, which led to an 88x cost reduction in its medium. As of March 2024, Mosa Meat operated the Center for Advanced Meat Production, Upscaling, and Sustainability (CAMPUS), a facility spanning over 79,000 sq ft that was designed to be expandable as demand grows.In <a href="https://sp-edge.com/updates/21645">September 2023</a>, Mosa Meat became the first cultivated meat company to attain B Corp certification. The company also announced plans to apply for regulatory approval in countries worldwide. In <a href="https://sp-edge.com/updates/21645">September 2023</a>, Mosa Meat became the first cultivated meat company to attain B Corp certification. The company also announced plans to apply for regulatory approval in countries worldwide. In <a href="https://sp-edge.com/updates/31970">July 2024</a>, it conducted the first official tasting of its cultivated beef product, the Mosa Burger, in the Netherlands. This event gathered Dutch cattle farmers, food product developers, and industry representatives to collect expert feedback.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/14175">November 2022</a>, Mosa Meat entered into an agreement with Singapore-based contract development and manufacturing organization (CDMO) Esco Aster to commercialize its cultivated beef in Singapore. Further, in <a href="https://sp-edge.com/updates/16845">March 2023</a>, the company partnered withNutreco to develop a cell feed supply chain that can expedite production and scalability while reducing cost.Funding and financialsIn its latest funding round in <a href="https://sp-edge.com/updates/28536">April 2024</a>, the company raised EUR 40 million (~USD 42.5 million) in an oversubscribed funding round co-led by Lowercarbon Capital and M Ventures, with participation from PHW Group, Invest-NL, LIOF, and LEF. The funds were earmarked for scaling production procedures, reducing production costs, and gearing up for commercialization.

Mosa Meat

SuperMeat is a cellular agriculture startup developing cultured chicken meat. The company uses chicken cells and claims to grow them in a culture medium free from antibiotics and contaminants to develop its products. SuperMeat also operates a test kitchen known as The Chicken. It is claimed to be the world’s first farm-to-fork facility where diners can observe the production of cultivated chicken.In <a href="https://sp-edge.com/updates/21733">September 2023</a>, The Orthodox Union (OU) certified SuperMeat’s cultivated chicken as “kosher.” Further, the OU and SuperMeat will collaborate on establishing guidelines for the industry.In&nbsp;<a href="https://sp-edge.com/updates/35765">November 2024</a>, the company announced it had achieved cost parity for its cultivated chicken and could produce it at at USD 11.79 per pound at scale, matching the price of premium US pasture-raised chicken.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/9319">March 2022</a>, SuperMeat signed an MoU with PHW to supply cultivated meat products including chicken, turkey, and duck to the European market. The company also <a href="https://sp-edge.com/updates/8997">partnered</a> with Ajinomoto to set up a joint venture to accelerate the commercialization of cultivated meat while focusing on developing a cost-competitive cell growth media.In <a href="https://sp-edge.com/updates/11867">July 2022</a>, the company signed an MoU with Switzerland’s largest retail supermarket chain and leading meat manufacturer, Migros to expedite production and distribution of cultured meat at a commercial scale with a focus on European markets.&nbsp;

SuperMeat

Uncommon (formerly HigherSteaks) is a UK-based cell-cultured meat startup that uses cellular agriculture to grow pork from animal cells. The company leverages cellular agriculture and in-house developed RNA technologies to cultivate meat and claims its technology eliminates the need for genetic engineering and growth media.In July 2020, the company unveiled the world's first lab-grown pork belly prototype and the second cell-based bacon (behind Mission Barns cell-based bacon unveiled in early 2020). The pork belly and the bacon were produced from a combination of cell-cultured muscle and plant-based proteins and fat. Uncommon plans to commercialize its cell-cultured meat by 2022-2025, pending regulatory approval.Funding and financialsIn <a href="https://sp-edge.com/updates/19267">June 2023</a>, the company raised USD 30 million in Series A funding co-led by Balderton Capital and Lower Carbon Capital, with participation from Redalpine, East Alpha, and others. The funds were earmarked for the development of its innovative approach, expanding production, increasing the team, and initiating regulatory approvals.

Uncommon

Multus, a spin-off of SOSV’s IndieBio program, is a biotechnology company that specializes in the development of growth media solutions for cellular agriculture applications. Its portfolio includes serum-free FBS alternatives (Proliferum M and Proliferum LSR) and solutions that support cell adhesion (rh-Vitronectin) during the cultivation process.Multus leverages MediOp, a growth media formulation design platform, to develop its solutions. According to the company, this technology allows optimizing solutions using automated data analysis and insights. Multus also uses this platform to provide contract manufacturing services for custom formulation design and food-safe manufacturing compliant with ISO22000 to customers in North America, Europe, and Asia-Pacific.In <a href="https://sp-edge.com/updates/25572">January 2024</a>, the company unveiled what it claims to be the first large-scale production plant making serum-free growth media in the cultivated meat industry.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/24911">December 2023</a>, the company partnered with New Wave Biotech, a bioprocess optimization software company, under a project funded through an Innovate UK Engineering Biology grant. Through this partnership, Multus planned to use New Wave Biotech’s AI software to optimize its process of developing precision-fermented ingredients for cell cultivation.Funding and financialsIn <a href="https://sp-edge.com/updates/15702">January 2023</a>, the company raised GBP 7.9 million (~USD 9.6 million) in a funding round led by Mandi Ventures with participation from SOSV, Big Idea Ventures, and others. The funding from this round was earmarked for the development of its animal-free growth media production facility in London.

Multus

Based in Israel, Believer Meats (Future Meat Technologies prior to November 2022) develops hardware and cell lines for the manufacturing of cell-cultured meat, to commercialize its manufacturing hardware and techniques.Believer Meats uses fibroblast cells that can be triggered with small molecules to develop either fat or muscle cells. Fat and muscle cells are cultured in a unique bioreactor that removes the waste material from the media, allowing the company to recycle parts of the media to reduce feed media input by as much as 50%. The startup replaced FBS with molecules derived from Chinese hamster ovaries (CHO) to reduce production costs and plans to achieve price parity with animal counterparts.In <a href="https://sp-edge.com/updates/12623">August 2022</a>, the company announced it has developed what it claims to be the world’s first cultivated lamb, using cell lines isolated from Awassi sheep.In <a href="https://sp-edge.com/updates/15195">December 2022</a>, the company announced it has begun development of a 200,000 sq foot production facility in Wilson, North Carolina with an annual capacity of ~22 million lbs, which is claimed to be the largest cultivation facility in the world. Believer Meats plans to produce cultured chicken, pork, beef, and lamb for US, European, and Asian markets.Key customers and partnershipsIn March 2022, the company <a href="https://sp-edge.com/updates/9320">partnered</a> with Charoen Pokphand Foods to develop cultivated meat products for Asia.In <a href="https://sp-edge.com/updates/17710">April 2023</a>, Believer Meats signed an MoU with Archer Daniels Midland (ADM) to collaborate on the development and commercialization of cultivated meat products. Further, ADM will offer its ingredient pantry and nutrition knowledge to enhance Believer's cell-cultivated meat process.In <a href="https://sp-edge.com/updates/30520">June 2024,</a> Believer Meats partnered with Abu Dhabi’s AgriFood Growth &amp; Water Abundance (AGWA), to advance cultivated meat production in the MENA region.Funding and financialsIn its <a href="https://sp-edge.com/updates/9252">latest funding round</a> in December 2021, the company raised USD 347 million in Series B funding, recording the largest investment in cell-cultured meat at the time. The round was co-led by ADM Ventures, while funds were to be used to accelerate its production plans in the US.

Believer Meats

Producers of cell-cultured seafood using cells extracted from fish. Startups have succeeded in developing prototypes of yellowtail and salmon

Producers of cell-cultured pork using cells extracted from animals. Startups have succeeded in developing prototypes of bacon and pork belly using cultured muscle and plant-based proteins and fat

Producers of cell-cultured beef using cells extracted from animals. Some producers in the industry are developing premium beef ranges such as Wagyu. Startups have only succeeded in developing prototypes in the minced form, with a few creating prototypes of (pieces of) steak using 3D bioprinters

Producers of cell-cultured chicken and duck using cells extracted from animals. Some producers in the industry are developing rare delicacies such as foie gras. Startups have only succeeded in developing products in the nugget form

Producers of growth media for cell-cultured meat production and ingredients for meat and meat analog (cell-cultured, plant-based) producers, which can include cell culture meat paste, culture fat, etc. Producers of growth media mainly focus on developing alternative growth media to FBS using plant-based or other sources

Developers of bioreactors and other technologies used in cell-cultured meat production. Industrial scaling and efficiency gains are key areas of interest for startups in the industry

Provide sustainable solutions for animal slaughter through the use of biotechnology

Future Fields

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless